1. Home
  2. CNH vs JAZZ Comparison

CNH vs JAZZ Comparison

Compare CNH & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNH Industrial N.V.

CNH

CNH Industrial N.V.

HOLD

Current Price

$13.75

Market Cap

19.1B

Sector

Industrials

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$245.87

Market Cap

16.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNH
JAZZ
Founded
1842
2003
Country
United Kingdom
Ireland
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1B
16.1B
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
CNH
JAZZ
Price
$13.75
$245.87
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$13.00
$217.57
AVG Volume (30 Days)
24.5M
884.4K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
0.99%
N/A
EPS Growth
N/A
N/A
EPS
0.12
7.17
Revenue
$18,095,000,000.00
$1,618,693,000.00
Revenue This Year
N/A
$6.22
Revenue Next Year
$8.21
$7.68
P/E Ratio
$113.17
$34.28
Revenue Growth
N/A
N/A
52 Week Low
$9.00
$124.50
52 Week High
$14.46
$266.38

Technical Indicators

Market Signals
Indicator
CNH
JAZZ
Relative Strength Index (RSI) 63.84 49.93
Support Level $10.00 $237.05
Resistance Level $14.46 $250.49
Average True Range (ATR) 0.56 6.76
MACD 0.11 -0.50
Stochastic Oscillator 67.84 37.55

Price Performance

Historical Comparison
CNH
JAZZ

About CNH CNH Industrial N.V.

CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agricultural sales are 40% in North America, 32% in Europe, the Middle East, and Africa, 18% in South America, and 10% in Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers and wholesale financing to dealers to maintain inventory, thereby supporting sales.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: